• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Polypharmacy, Chronic Kidney Disease, and Benign Prostatic Hyperplasia in Patients with Chronic Obstructive Pulmonary Disease Newly Treated with Long-Acting Anticholinergics.

作者信息

Kaplan Steven A

出版信息

J Urol. 2019 Jul;202(1):6-7. doi: 10.1097/01.JU.0000557737.50592.3d. Epub 2019 Jun 7.

DOI:10.1097/01.JU.0000557737.50592.3d
PMID:30958737
Abstract
摘要

相似文献

1
Re: Polypharmacy, Chronic Kidney Disease, and Benign Prostatic Hyperplasia in Patients with Chronic Obstructive Pulmonary Disease Newly Treated with Long-Acting Anticholinergics.回复：慢性阻塞性肺疾病患者新接受长效抗胆碱能药物治疗时的多重用药、慢性肾脏病和良性前列腺增生
J Urol. 2019 Jul;202(1):6-7. doi: 10.1097/01.JU.0000557737.50592.3d. Epub 2019 Jun 7.
2
Polypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics.慢性阻塞性肺疾病患者新接受长效抗胆碱能药物治疗时的多重用药、慢性肾脏病和良性前列腺增生
Respir Med. 2017 Nov;132:195-202. doi: 10.1016/j.rmed.2017.10.023. Epub 2017 Oct 31.
3
Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者吸入长效支气管扩张剂的心血管安全性。
JAMA Intern Med. 2013 Jul 8;173(13):1175-85. doi: 10.1001/jamainternmed.2013.1016.
4
Re: Association between Chronic Obstructive Pulmonary Disease and Increased Risk of Benign Prostatic Hyperplasia: A Retrospective Nationwide Cohort Study.关于：慢性阻塞性肺疾病与良性前列腺增生风险增加之间的关联：一项全国性回顾性队列研究。
J Urol. 2018 Dec;200(6):1138-1141. doi: 10.1016/j.juro.2018.09.012.
5
Inhaled long-acting β-agonists versus anticholinergics in older patients with chronic obstructive pulmonary disease.长效吸入型β受体激动剂与抗胆碱能药物用于老年慢性阻塞性肺疾病患者的比较
Ann Intern Med. 2011 Oct 18;155(8):561; author reply 561-2. doi: 10.7326/0003-4819-155-8-201110180-00018.
6
Anticholinergics in the treatment of chronic obstructive pulmonary disease.抗胆碱能药物在慢性阻塞性肺疾病治疗中的应用
Respiration. 2002;69(4):372-9. doi: 10.1159/000063278.
7
Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease.慢性肾脏病：慢性阻塞性肺疾病老年患者多病共存中可能被低估的一个组成部分。
Geriatr Gerontol Int. 2017 Nov;17(11):1770-1788. doi: 10.1111/ggi.13054. Epub 2017 May 16.
8
Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.
JAMA. 2009 Mar 25;301(12):1224; author reply 1225-6. doi: 10.1001/jama.2008.950.
9
Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.在初级保健中，慢性阻塞性肺疾病药物的依从性较差：年龄、疾病负担和多种药物治疗的作用。
Geriatr Gerontol Int. 2017 Dec;17(12):2500-2506. doi: 10.1111/ggi.13115. Epub 2017 Jun 28.
10
Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.比较吸入长效β-激动剂和抗胆碱能药物对老年慢性阻塞性肺疾病患者的疗效：一项队列研究。
Ann Intern Med. 2011 May 3;154(9):583-92. doi: 10.7326/0003-4819-154-9-201105030-00003.